<DOC>
	<DOC>NCT00159614</DOC>
	<brief_summary>The purpose of this study is to characterize the safety and tolerability of KW-3902IV and measure its effect on renal function.</brief_summary>
	<brief_title>Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Rolofylline</mesh_term>
	<criteria>Stable congestive heart failure Impaired renal function Taking oral loop diuretic Acutely decompensated (unstable) and end stage heart failure Diuretics other than loop diuretics Pregnant or nursing Inability to follow instructions Participation in another clinical trial within past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>renal insufficiency</keyword>
	<keyword>diuretic</keyword>
	<keyword>heart failure, congestive</keyword>
</DOC>